Quantum-Si, Inc. (QSI)
0.909
-0.16
(-15.05%)
USD |
NASDAQ |
Nov 20, 16:00
0.94
+0.03
(+3.41%)
After-Hours: 20:00
Quantum-Si Enterprise Value : 99.02M for Nov. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 99.02M |
| November 19, 2026 | 134.39M |
| November 18, 2026 | 134.39M |
| November 17, 2026 | 121.21M |
| November 16, 2026 | 132.20M |
| November 13, 2026 | 151.97M |
| November 12, 2026 | 167.36M |
| November 11, 2026 | 178.34M |
| November 10, 2026 | 180.54M |
| November 09, 2026 | 200.32M |
| November 06, 2026 | 191.53M |
| November 05, 2026 | 156.37M |
| November 04, 2026 | 182.74M |
| November 03, 2026 | 184.94M |
| November 02, 2026 | 176.15M |
| October 30, 2026 | 220.09M |
| October 29, 2026 | 283.82M |
| October 28, 2026 | 277.23M |
| October 27, 2026 | 261.84M |
| October 26, 2026 | 220.09M |
| October 23, 2026 | 206.91M |
| October 22, 2026 | 151.97M |
| October 21, 2026 | 169.55M |
| October 20, 2026 | 154.17M |
| October 19, 2026 | 138.79M |
| Date | Value |
|---|---|
| October 16, 2026 | 145.38M |
| October 15, 2026 | 187.13M |
| October 14, 2026 | 204.71M |
| October 13, 2026 | 209.11M |
| October 12, 2026 | 198.12M |
| October 09, 2026 | 235.48M |
| October 08, 2026 | 167.36M |
| October 07, 2026 | 180.54M |
| October 06, 2026 | 167.36M |
| October 05, 2026 | 180.54M |
| October 02, 2026 | 239.87M |
| October 01, 2026 | 213.50M |
| September 30, 2026 | 134.39M |
| September 29, 2026 | 101.22M |
| September 28, 2026 | 65.52M |
| September 25, 2026 | 74.13M |
| September 24, 2026 | 63.34M |
| September 23, 2026 | 57.58M |
| September 22, 2026 | 63.27M |
| September 21, 2026 | 56.97M |
| September 18, 2026 | 54.60M |
| September 17, 2026 | 60.05M |
| September 16, 2026 | 51.32M |
| September 15, 2026 | 49.11M |
| September 14, 2026 | 50.20M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Champions Oncology, Inc. | 67.59M |
| Medpace Holdings, Inc. | 16.50B |
| Avantor, Inc. | 13.28B |
| Personalis, Inc. | 1.393B |
| Adaptive Biotechnologies Corp. | 4.630B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -22.32M |
| Revenue (Quarterly) | 0.212M |
| Total Expenses (Quarterly) | 22.53M |
| EPS Diluted (Quarterly) | -0.1019 |
| Gross Profit Margin (Quarterly) | -531.1% |
| Profit Margin (Quarterly) | -10.53K% |
| Earnings Yield | -43.37% |
| Normalized Earnings Yield | -43.76 |